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httpPredictors of percutaneous access failure requiring
open femoral surgical conversion during
endovascular aortic aneurysm repair
Albeir Y. Mousa, MD,a John E. Campbell, MD,a Mike Broce, BA,b Shadi Abu-Halimah, MD,a
Patrick A. Stone, MD,a Stephen M. Hass, MD,a Ali F. AbuRahma, MD,a and Mark Bates, MD,a
Charleston, WVa
Objective: To determine predictors of percutaneous (PEVAR) access failure requiring conversion to an open approach
(OEVAR) during endovascular aortic aneurysm repair (EVAR).
Methods: A single-center retrospective review of all EVAR patients from January 2009 through June 2011 with multi-
variate analysis of clinical and anatomic variables that could impact access outcome was conducted. Target vessel calci-
ﬁcation was categorized as mild, moderate, or severe based on circumferential calcium arc (<1/3, 1/3 to ½, and >½
respectively), dyslipidemia (deﬁned as low-density lipoprotein >130 mg/dL or receiving lipid lowering medication), and
obesity (deﬁned as body mass index [BMI] >30).
Results: We investigated 400 access sites for 200 patients who underwent EVAR. The study cohort’s characteristics
included an average age of 72.86 9.0 years, vessel size of 9.6 6 1.8 mm, sheath size of 17.16 3.0 Fr, BMI of 27.66 5.3,
and estimated glomular ﬁltration rate of 68.5 6 24.2 mL/min. Comorbidities included dyslipidemia in 129 patients
(64.5%) and diabetes in 54 patients (27%). There were 132 OEVAR (66 patients), two mixed OEVAR with contralateral
PEVAR (one patient), and 266 (133 patients) PEVAR approaches. Use of PEVAR increased over time (45.5% [2009],
77.8% [2010], and up to 88.5% [2011]; P [ .001) while conversions decreased (24.3% [2009], 8.7% [2010], and
4.3% [2011]; P [ .001]. More OEVAR patients (35.8%) stayed longer than 3 days compared with 21.1% for PEVAR
(P[ .028). For the 266 PEVAR approaches, 32 access sites (12.0%) had to be converted. Severely calciﬁed arteries were
most predictive of conversion (odds ratio [OR], 36.4; P < .001). Year of procedure (2010; OR, 0.17; P [ .001; 2011,
OR, 0.20; P [ .049), female gender (OR, 3.1; P [ .017), moderately calciﬁed arteries (OR, 2.5; P [ .085), and
age (OR, 2.3 [per decade]; P [ .002) were all also signiﬁcant. Vessel size, sheath size, and BMI were found to be
nonsigniﬁcant predictors of conversion.
Conclusions: PEVAR was found to be safe, reliable, and feasible. Several factors, including learning curve, vessel calciﬁ-
cation, age, and female gender predicted conversion of PEVAR to OEVAR. (J Vasc Surg 2013;58:1213-9.)Endovascular aortic aneurysm repair (EVAR) has
matured into an appealing minimally invasive surgical alter-
native for patients with abdominal aortic aneurysms with
feasibility, reliability, and durability conﬁrmed in multiple
national and international clinical trials.1-9 Surgical common
femoral access was mandatory at the initiation of our EVAR
program in the mid-1990s, since ﬁrst generation devices
required 28 to 30 French (F) sheaths. The advent of
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led our center, along with others, to explore percutaneous
endovascular repair alternatives for EVAR in recent years.
It seems intuitive that percutaneous access could be better
tolerated in select patients and should have a lower risk of
complications. However, any new elegant procedural
enhancement such as percutaneous endovascular aortic
aneurysm repair (PEVAR) with SMCDs requires detailed
systematic review to deﬁne predictors and consequences of
failure. Many studies have evaluated the percutaneous
approach with different outcome measures,10-19 and it is
clear that PEVAR is feasible and can be performed safely
and efﬁciently. However, there remains signiﬁcant contro-
versy related to the predictors of conversion to open endo-
vascular aortic aneurysm repair (OEVAR) following
PEVAR.11-15,18,20-24 The main objective of this study is
to evaluate and determine the signiﬁcant predictors of
conversion.
METHODS
We performed a retrospective single cohort analysis at
Charleston Area Medical Center, which was approved by
our governing Institutional Review Board and conducted
in accordance with the Health Insurance Portability and1213
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principles governing research. This study was designed to
be a retrospective review from January 2009 to June
2011 of all patients who underwent EVAR. While much
of the data was obtained from a prospectively maintained
endovascular database, some additional data elements
were obtained from chart review of electronic medical
records. Collected data included demographics, comorbid-
ities, and procedure-related characteristics, including artery-
speciﬁc information. Vessel size was determined using the
axial cut of the computed tomography (CT) scan. The
diameter of the common femoral artery was measured
in mm at a distance of 1 cm proximal above the origin of
the profunda femoris artery, outer wall to outer wall at
the widest diameter of the artery. The degree of access
vessel calciﬁcation was measured according to the amount
of calciﬁcation present around the circumference of the
access artery on CT. Based on the percentage of the
circumference, calciﬁcation was deﬁned as mild (<1/3),
moderate (1/3 to ½), or severe (>½; Figs 1 and 2). Access
vessel anatomical calciﬁcation orientation was classiﬁed
into medial, posterior, or anterior.
Statistical analysis. All analyses were performed using
SPSS version 17.0 (SPSS Inc, Chicago, Ill). Descriptive
statistics are reported in terms of frequencies, percentages,
or means 6 one standard deviation. Categorical variables
were tested by c2 or Fisher exact tests, and continuous vari-
ables were tested by Student t-test where deemed appro-
priate. A P value of .05 or less was considered signiﬁcant.
The primary outcome variable was surgical conversion
and was deﬁned as the need for OEVAR following attemp-
ted PEVAR. Multivariate testing was conducted by
including all potential covariates into a backwards stepwise
logistic regression model to predict OEVAR.
Patient management and operative procedure. The
technique for PEVAR was standardized in our institution.
Access to the common femoral artery was achieved using
B model ultrasound guidance in both groins in all patients
(Phillips IU22, transducer L9-3; Phillips, Oceanside,
Calif). Careful evaluation of common femoral vessels,
take-off of the profunda femoris artery, and location and
distribution of calciﬁcation were achieved during that
phase. Arterial puncture was performed at approximately
a 45 angle, and the anterior wall was punctured.
Our technique was similar to the one described by
Lee and associates,19 consisting of the deployment of two
Perclose ProGlide Suture-Mediated Closure System devices
(Abbott Vascular, Redwood City, Calif). The sutures were
deployed diagonally (usually at 10 and 2 o’clock) in each
artery bilaterally prior to placement of the large sheath and
endograft. The two sutures were left extra-corporeally for
complete closure at the end of the procedure. At the end
of aneurysm exclusion, the large bore sheath was retracted
over an appropriate guide wire. Gentle proximal pressure
was applied over the indicated vessel while the knots were
advanced to the artery. If bleeding was well controlled,
the guide wire was removed, and each knot was further
advanced to the artery and “locked” in place. If therewas stilla signiﬁcant bleed, the sheath with a dilator was advanced,
and another perclose device was attempted to be deployed
in a different orientation. If hemostasis could not be
achieved, then the sheath was reinserted, and an open repair
was performed by dissecting down to the common femoral
artery with the sheath left in place. Once the cutdown was
performed, the arteriotomy was repaired in a standard
fashion.
DEFINITIONS
1. Vessel calciﬁcations:
a. Mild: vessel calciﬁcation was less than 33% of
vessel circumference.
b. Moderate: vessel calciﬁcation was more than 33%
and less than 50% of vessel circumference.
c. Severe: vessel calciﬁcation was more than 50%.
d. Each vessel was coded as medial, anterior, or
posterior according to location of calciﬁcation.
2. Estimated glomerular ﬁltration rate (eGFR) was
deﬁned as 186.3  serum creatinine1.154 
age0.203  0.742 (if female)  1.212 (if African
American)
3. Technical success was deﬁned as achieving complete
hemostasis without the need to perform any groin
cutdown or without the occurrence of any local
access complications such as pseudoaneurysms, limb
ischemia, or dissection.
4. Technical failure or conversion was deﬁned if groin
cutdown and open surgical procedure was needed
as a result of closure device failure or malfunction.
5. Groin hematoma:
a. Small: if less than 5 cm
b. Large: if more than 5 cm
6. Wound complications: Any lymphocele, infection, or
thrombosis present.
7. Obesity: body mass index (BMI) >30 kg/m2RESULTS
We investigated 400 access site approaches for 200
patients who electively underwent EVAR with an overall
average (mean 6 standard deviation) age of 72.8 6 9.0
years. The average BMI and eGFR were 27.6 6 5.3 and
68.5 6 24.2 mL/min, respectively. The most common
comorbidities for the 200 patients included histories of dys-
lipidemia (129; 64.5%) and diabetes (54; 27%). The access
site approaches were categorized based on how they were
initially treated. There were 132 OEVAR approaches
utilized for 66 patients. The 132 OEVAR arteries were
treated with open endartrectomy followed by patch angio-
plasty, and one interposition graft was utilized in that
cohort. A total of 266 PEVAR approaches were used for
133 patients, while one patient received a mixed approach,
one OEVAR and one PEVAR.
For the most part, the baseline patient demographics
and characteristics between the two groups (OEVAR and
PEVAR) were very similar (see Table I for more details).
Fig 2. A, Axial computed tomography (CT) angiogram at the level of common femoral artery demonstrating mild
(<33%) calciﬁcation. Note the scout view of level of the image. B, Axial CT angiogram at the level of common femoral
artery demonstrating moderate (33%-50%) calciﬁcation. Note the scout view of level of the image. C, Axial CT
angiogram at the level of common femoral artery demonstrating severe (>50%) calciﬁcation. Note the scout view of
level of the image.
Fig 1. Classiﬁcation for target vessel calciﬁcation.
Table I. Demographic and patient characteristics
Variable
OEVAR (n ¼ 66) PEVAR (n ¼ 133)
PNo. or mean % or standard deviation No. or mean % or standard deviation
Male gender 54 81.8 108 81.2 .916
Age, yearsa 73.7 7.8 72.4 9.6 .362
BMIa 27.2 5.5 27.8 5.2 .473
BMI >30 18 27.3 38 28.6 .848
Acute myocardial infarction 0 0.0 0 0.0 –
Cardiovascular disease 7 10.6 21 15.8 .322
eGFRa 72.3 25.6 67.0 23.2 .144
eGFR <30 1 1.5 8 6.0 .276
Dyslipidemia 40 60.6 88 66.2 .530
Congestive heart failure 6 9.1 9 6.8 .576
Diabetes 24 36.4 30 22.6 .044
BMI, Body mass index; eGFR, estimated glomerular ﬁltration rate; OEVAR, open endovascular aortic aneurysm repair; PEVAR, percutaneous endovascular
aortic aneurysm repair.
aMean 6 standard deviation.
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(9.6 mm) and PEVAR (9.7 mm; P ¼ .565). Also, the
average sheath size used during the procedure did not
differ between OEVAR (17.2F) and PEVAR (17.0F;
P ¼ .646; Table II).
The outcomes for the patients receiving OEVAR were
compared with those receiving PEVAR, and there were no
in-hospital deaths in either group. There was one dissection,
one urinary infection, and one groin infection in the
OEVAR group (0.8% for each), but this was not signiﬁcantlydifferent than no cases found in the PEVAR group (P ¼
.332). There was no difference in 1.5% (two cases) acutely
occluded arteries contributing to acute limb ischemia in
the open group compared with 2.2% (six cases) in the
PEVAR group (P¼ 1.00). The number of small hematomas
in the OEVAR group (n ¼ 2; 1.5%) did not signiﬁcantly
differ from those in the PEVAR group (n ¼ 6; 2.2%; P ¼
.67). However, there were signiﬁcantly more large hema-
tomas in the OEVAR group (n ¼ 5; 3.8%), as compared
with the PEVAR group (n ¼ 2; 0.7%; P ¼ .031). The
Table II. Average sheath and vessel size by operative group
Variable Group No. Mean Standard deviation Minimum Maximum P
Sheath OEVAR 133 17.2 3.0 12 24
Size, F PEVAR 267 17.0 3.0 12 24 .646
Vessel OEVAR 133 9.6 1.7 6.1 15.5
Size, mm PEVAR 267 9.7 1.8 4.7 15.9 .565
OEVAR, Open surgical endovascular aortic aneurysm repair; PEVAR, percutaneous endovascular aortic aneurysm repair.
Table III. Signiﬁcant predictors of conversion to
OEVAR
Variable OR
95% CI
PLower Upper
Age (by decade) 2.35 1.37 4.02 .002
Year 1 (2009) Reference
Year 2 (2010) 0.17 0.06 0.47 .001
Year 3 (2011) 0.20 0.04 0.99 .049
Female gender 3.14 1.22 8.07 .017
Moderate calciﬁcation 2.48 0.88 7.00 .085
Severe calciﬁcation 36.42 7.70 172.29 .000
CI, Conﬁdence interval; OEVAR, open surgical endovascular aortic aneu-
rysm repair; OR, odds ratio.
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(41%) after 1 day and 148 (74%) within 3 days or less, while
52 (26%) had a stay of over 3 days. It was found that 35.8%
of OEVAR patients stayed longer than 3 days compared
with 21.1% for PEVAR (P ¼ .028).
For the 266 PEVAR approaches, 32 (32/266; 12.0%)
had to be converted to OEVAR during the intervention.
The percentage of approaches attempted by PEVAR
increased over the study period from 45.5% in 2009,
77.8% in 2010, and up to 88.5% during the ﬁrst half of
2011 (P ¼ .001), while conversion decreased (24.3% in
2009, 8.7% in 2010, and 4.3% in 2011; P ¼ .001). The
majority of arteries were mildly calciﬁed (77.8%), while
the remainder were either classiﬁed as moderate (19.0%)
or severe (3%). In the majority of cases, the calciﬁcation
occurred in the posterior region (92.8%) as opposed to
the anterior (7%) or medial (0.3%) regions. Although the
percentage of moderate or severely calciﬁed arteries did
not signiﬁcantly differ over the time period, there was
a trend towards fewer severely calciﬁed vessels attempted
at the end of the study period (24.3% in 2009, 27.3% in
2010, and 10.9% in 2011; P ¼ .071). The group of
PEVAR patients who had to be converted (con) compared
with the ones without conversion (no-con) were older
(78.0 6 6.5 vs 71.8 6 9.6 years; P < .001), consisted of
more females (34.4% vs 16.7%; P ¼ .027), and had more
moderate or severe calciﬁcations (46.9% vs 20.5%; P ¼
.003). There were no differences between con vs no-con
for average eGFR (64.2 6 23.8 vs 67.3 6 23.1; P ¼
.481), BMI (26.8 6 5.8 vs 27.9 6 5.1; P ¼ .252), vessel
size (9.2 6 2.0 vs 9.7 6 1.7 mm; P ¼ .155), or sheath
size (17.5 6 3.0 vs 16.9 6 3.0 Fr, P ¼ .270), respectively.
In addition, there were no signiﬁcant differences between
con vs no-con in the bi-variate relationships for low renal
function (eGFR <30, 6.3% vs 6.0%; P ¼ .952), obesity
(BMI >30, 31.3% vs 28.2%; P ¼ .683), severely obese
(BMI >35, 5.9% vs 8.2%; P ¼ .737), or large bore sheath
size ($20 Fr, 25.0% vs 19.7%; P ¼ .485), respectively.
A multivariate analysis showed that severely calciﬁed
arteries were most predictive of OEVAR conversion
(odds ratio [OR], 36.4; P < .001). Female gender
(OR, 3.1; P ¼ .017), moderately calciﬁed arteries (OR,
2.5; P ¼ .085), and age (OR, 2.3, per decade; P ¼ .002)
were all associated with an increased risk of conversion to
OEVAR, while the year of procedure (2010 OR, 0.17;
P ¼.001; 2011 OR, 0.20; P ¼ .049) was associated with
a decreased risk (see Table III for details).DISCUSSION
Most respected authorities agree that many access
complications may occur after open groin access during
EVAR, namely, seroma up to 11%,1,15 wound infection,17
and thrombosis of the access vessel. In addition, increased
procedure time and amount of blood loss were reported
with the open approach.1,15,25 The feasibility of PEVAR
has been documented in many studies,26-29 not only for
elective, but even with ruptured aneurysmal repair.18 The
Kaiser group, in their recent retrospective analysis of 101
patients, reported a 90% success rate with a total percuta-
neous approach. After adjusting for obesity and smoking,
predictors of conversion in that study were mechanical
failure of percutaneous devices and ultrasound guidance
to access vessels.10 To broaden the spectrum for applying
PEVAR, a prospective randomized study from 19 institu-
tions participating in a PEVAR clinical trial (utilizing Pro-
Glide or ProStar XL closure devices; Perclose Inc.,
Redwood City, Calif) reported a 97% clinical success rate
(one patient required surgical intervention among the
38).20 Similar results were also reported in a recent system-
atic review of PEVAR performed on 1087 patients with
a technical success rate of 92%, access-related complication
rate of 4%, and a decreased operative time was noted when
compared with the OEVAR group.23
There is no doubt that the main adjunct and gate-
keeper for percutaneous access is utilizing ultrasound-
guided needle puncture. The PEVAR technique requires
both a precise puncture of the access artery and a signiﬁcant
anatomical understanding of the arterial anatomy, such as
the amount of calciﬁcation, vessel size, and to ensure that
JOURNAL OF VASCULAR SURGERY
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bifurcation.30 In our study, ultrasound was used exclusively
and rendered a technical success rate of 100% for vessel
cannulation. Other respected authorities have reported
similar results with the utilization of ultrasound as
well.10,11,14-16,24,25,31,32 Although technical success has
been reported to be between 45% and 100% in multiple
studies, our study indicates that experience and a full
understanding of all the ramiﬁcations of the PEVAR tech-
nique are cornerstone components for technical success.
Beshara et al reported that technical success improves as
surgeons gain experience with the SCMD, but previous
experience with the Proglide device did not seem to inﬂu-
ence the learning curve.11 In our study, we noted an
increase in the utilization of PEVAR over time (45.5% in
2009, 77.8% in 2010, and up to 88.5% in 2011; P ¼
.001), while conversions decreased (24.3% in 2009, 8.7%
in 2010, and 4.3% in 2011; P ¼ .001). This ﬁnding goes
hand in hand with the learning curve for clinicians and is
also supported by a similar ﬁnding in the multivariate
results as well. The odds ratio for conversion was lower
in the second and third year of the study period (OR,
0.17 and 0.20, respectively).
Normally, among many predictors of conversion, vessel
calciﬁcation and diameter carry the most weight for clini-
cians when it comes to preoperative planning for PEVAR.
Severe access calciﬁcations, especially throughout the
iliac systems, have been attributed to direct signiﬁcant
morbidity and mortality. In these situations, a valid alterna-
tive access is pursued, such as the iliac artery for a conduit
or uni-body EVAR with extra-anatomical bypass.33 Smith
et al15 demonstrated no signiﬁcant difference in conversion
with regard to vessel calciﬁcations between the PEVAR and
OEVAR groups. Although their study used the Agatston
score as a weighted value assigned to the highest density
of calciﬁcation, there were no speciﬁcations related to the
distribution of calciﬁcation in the arterial wall, which may
be more pertinent to case planning. We echo this ﬁnding
as well, and suggest that severe vessel calciﬁcation, as
deﬁned by more than ½ of the circumference in the target
access vessel on CT scan, was found to be the most predic-
tive factor of conversion (OR, 36.4; P < .001).
As mentioned above, PEVAR utilization increased
and conversion decreased over time. In addition, the
percentage of moderate or severely calciﬁed arteries did
not signiﬁcantly differ over the time period, but there was
a trend towards fewer severely calciﬁed vessels attempted
at the end of the study period (24.3% in 2009, 27.3% in
2010, and 10.9% in 2011; P¼ .071). These ﬁndings suggest
that clinicians may have used information gathered during
the study period to aide their pre-procedure decision-
making process. More speciﬁcally, they may have chosen
the OEVAR for the more severely calciﬁed cases instead
of starting the procedure with PEVAR. We do believe
clinicians’ decisions were inﬂuenced by experience and
new available information, such as the knowledge that
more severely calciﬁed cases often result in conversion, but
at the same time, our study was not randomized. As wemention later, in the limitations section, the decision to
use either technique (PEVAR or OEVAR) was and still is
purely up to the clinician at the time of the procedure.
Other research has suggested that a minimal vessel
diameter <5 mm in comparison with 6.8 mm is associated
with technical failure (OR, 7.3; conﬁdence interval [CI],
1.58-33.8; P ¼ .01).28 In the same study, neither calciﬁca-
tion nor BMI were directly related to technical failure.11 In
our study, vessel size was not a predictor of open conver-
sion or device failure. Perhaps our results should be consid-
ered with caution because the majority of our patient
cohort was male with a perceived larger vessel size.
Although many will indicate that larger-bore femoral
access sheaths ($20F) increase the chance of open conver-
sion,13 we found no increase in the percentage of large-
bore sheaths used for patients in the con group when
compared with those in the no-con group (25.0% vs
19.7%, respectively; P ¼ .485).
Etzadi reported a similar conclusion in his retrospective
study of 100 PEVARs, in that calciﬁcation, obesity, and
sheath size, as well as vessel size, were not predictors of
failure.21 Smith et al showed that calciﬁcation and BMI
>30 were not contraindications for PEVAR. Interestingly,
in the same report, vessel pre- and postoperative CT-
derived anatomic data showed a signiﬁcant decrease in
the minimal vessel area with OEVAR compared with
PEVAR (P ¼ .02).15 Another report by Rachel et al34
conﬁrmed that gender, obesity, calciﬁcation, and previous
groin access were not predicative of device failure;
however, sheath size was.
Lee et al19 evaluated factors contributing to conversion
for 16 failures out of 279 femoral arteries. Intuitively,
success rates for 12F- to 16F-size sheaths were signiﬁcantly
higher than those for 18F- to 24F-size sheaths.
Another important advantage to PEVAR is its
perceived shorter overall procedure time, decreased
hospital stay, and decreased procedure-related morbidities.
In the current study, 35.8% of OEVAR patients stayed
longer than 3 days compared with 21.1% for PEVAR
(P ¼ .028). Minion et al demonstrated, in a large compar-
ative study between PEVAR and OEVAR using the Amer-
ican College of Surgeons National Surgical Quality
Improvement Program Database, that operative time was
signiﬁcantly less with PEVAR (159 6 63 minutes vs
150 6 68 minutes; P < .05). On the other hand, the
same study indicated that 1-month serious morbidity was
more common with PEVAR (5.8% vs 7.2%; P < .05),
with a risk-adjusted OR of 1.31 (95% CI, 1.03-1.68).
However after adjusting for other comorbidities, there
was no signiﬁcant difference in the 1-month mortality
rate or length of stay (LOS) for OEVAR (0.8% and 2.9
days) compared with PEVAR (0.9% and 3.3 days).35
Cost-effectiveness has been evaluated in some reports,
and while PEVAR is associated with a decreased LOS,
this beneﬁt may be negated by the price of the device.
Both Jean Baptiste36 from Europe and Lee19 from the
U.S. have indicated that the difference in the LOS was
associated with a reduced cost for PEVAR; however, that
JOURNAL OF VASCULAR SURGERY
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closure devices.
There are only two published prospective randomized
studies comparing OEVAR with PEVAR. The ﬁrst one
was conducted in 19 centers for PEVAR over a 1-year
period with a reported technical success rate of 96%, sup-
porting the safety and feasibility of PEVAR.20 The second
one was an older study, which was conducted in one center
and randomized 30 patients to either PEVAR or OEVAR.
This study concluded that PEVAR is safe, feasible, and has
a shorter operative time and time to ambulation.1
Intuitively, one may think that sheath size plays a signif-
icant role in the outcome of PEVAR and also directs the
number of preapplications of SMCDs. However, in the
current study, we found no evidence that sheath size was
associated with conversion. In contrast, a recent meta-
analysis of 2447 femoral accesses in 1440 patients, which
included one randomized controlled, eight prospectively
observational, and eight retrospective studies, demon-
strated that a sheath size >20F was a predictor of conver-
sion to open femoral cutdown. This review also indicated
that large-bore SMCDs may decrease technical failure of
PEVAR, and pre-planned deployment of two SMCDs is
required for a better outcome when an 18F sheath is
used.13
Our study detailed the importance of vessel calciﬁcations
as a potential predictor of conversion. Vessel calciﬁcationwas
deﬁned according to the size of the circumference of the
affected area as mild, moderate, or severe, while location
was classiﬁed as medial, anterior, or posterior. Although
we found, and agree with others, that severe calciﬁcation
carries a direct impact on possible conversion, we did not
ﬁnd statistical signiﬁcance for anterior calciﬁcation alone to
be prohibitive for PEVAR. This lack of effect for the anterior
location in the ﬁnal regression model could, perhaps, be due
to the relatively small number of patients in our series with
anterior calcium and the dominant statistical impact based
on the presence of a large arc of calcium. The extent of the
arc of calcium appears to bemore important than the calcium
location, and this suggests that arc measurements may be
a surrogate for circumferential vessel noncompliance and
objective marker calcium severity. In addition, we used
pre-procedure CT mapping and meticulous ultrasound
puncture guidance to avoid known islands of anterior
calcium. On the other hand, this ﬁnding could be due to
some of the factors listed below in the limitations section.
To date, only one available study has detailed the importance
of anterior calciﬁcation as a predictor for conversion.16
There are some limitations to our study. First, due to
the retrospective study design, as well as decisions made
by clinicians, it is possible that selection bias inﬂuenced
the outcomes. We only investigated physician experience
as a group and not individually. We were also limited to
data collected during the study period and did not collect
any prior experience of ProGlide. Although the majority
of the current study cohort was male, the signiﬁcant female
gender variable (associated with smaller vessels) was
collinear with and resulted in the removal of vessel sizefrom the ﬁnal model. In addition, target vessel diameter
was measured outer to outer wall, and this may have
resulted in underestimating the effect of vessel size. It is
possible that a much larger, more heterogeneous sample
would allow both variables to remain signiﬁcant. It is plau-
sible that the current method to classify the amount and
location of the calciﬁcation lacked the precision necessary
to provide more and better predictors of conversion. It is
also highly plausible that recent advances in technology,
including SMCDs and low-proﬁle grafts, have increased
the use of PEVAR and reduced the need for conversion.
Our study was also limited to the data that were available
at the time of analysis. Variables that were unmeasured or
not recorded could also be important predictors of conver-
sion. And ﬁnally, it is likely that during the learning
process, clinicians gained knowledge and/or developed
some pre-procedure strategies that lessened the need for
conversion during the study period. The multivariate statis-
tical model was utilized to overcome some of these short
falls, but conclusive level 1 evidence will require additional
testing.
CONCLUSIONS
Operator experience and severe calciﬁcation of the
access vessels appear to be important predictors inﬂuencing
the success of PEVAR. Age and female gender are also
important risk factors, but surprisingly, access vessel diam-
eter and device proﬁle do not appear to have a signiﬁcant
impact on outcomes. Additional well-controlled trials are
needed to further deﬁne when PEVAR should be avoided.
However, in the meantime, we suggest analyzing pre-
procedure CT scans for common femoral artery calcium
arcs, obtaining signiﬁcant experience with suture-based
closure devices before starting a program in order to opti-
mize the learning curve, and meticulous ultrasound-guided
arterial puncture. In addition, most pre-close systems are
off-label, and informed consent should include a discussion
on that front.
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